Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

COVİD-19 Pnömonisi Gelişen Hastalarda Vitamin D Düzeylerinin Hastane Yatış Süresi ve Mortalite ile İlişkisinin Değerlendirilmesi: Retrospektif Analiz

Tanriverdi et al., International Journal of Tokat Medical Sciences, 17:18-25, Apr 2025
https://c19early.org/tanriverdi2.html
Mortality 60% Improvement Relative Risk Vitamin D for COVID-19  Tanriverdi et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 178 patients in Turkey (June 2020 - December 2022) Lower mortality with higher vitamin D levels (not stat. sig., p=0.071) c19early.org Tanriverdi et al., Int. J. Tokat Medic.., Apr 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 125 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
5,700+ studies for 135 treatments. c19early.org
Retrospective 178 hospitalized COVID-19 pneumonia patients showing higher mortality with lower vitamin D levels.
This is the 217th COVID-19 sufficiency study for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 63,753,630,414 vigintillion).
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of death, 59.6% lower, RR 0.40, p = 0.07, high D levels (≥30 ng/mL) 4 of 52 (7.7%), low D levels (<30 ng/mL) 24 of 126 (19.0%), NNT 8.8.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Tanriverdi et al., 30 Apr 2025, retrospective, Turkey, peer-reviewed, mean age 64.0, 1 author, study period 1 June, 2020 - 31 December, 2022. Contact: drfbhakante@gmail.com.
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit